Pacer Advisors
AKAO

Pacer Advisors’s Achaogen Inc AKAO Stock Holding History

Pacer Advisors’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-310
Closed -$1K – 1179
2018
Q3 		$1K Buy
+310
New +$1.87K ﹤0.01% 1192
2018
Q1 		– Sell
-2,075
Closed -$22K – 1182
2017
Q4 		$22K Buy
+2,075
New +$26K ﹤0.01% 1091

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors's AKAO Position: Q4 2018 in Review

Pacer Advisors sold out of Achaogen Inc (AKAO) in Q4 2018, closing a stake of 310 shares — an estimated $1K sold.

Pacer Advisors first reported a position in AKAO in Q4 2017 and held it in 2 quarters. The position peaked at $22K in Q4 2017. 78 funds tracked by Wall St. Rank hold AKAO as of Q4 2018.

  • Pacer Advisors reported no remaining Achaogen Inc position as of Q4 2018 after selling out during the quarter.
  • Pacer Advisors sold 310 Achaogen Inc shares in Q4 2018, an estimated $1K.
  • Pacer Advisors first reported a position in Achaogen Inc in Q4 2017 and held it in 2 quarters.
  • Pacer Advisors's Achaogen Inc position peaked at $22K in Q4 2017.
  • 78 funds tracked by Wall St. Rank held Achaogen Inc as of Q4 2018.

Based on Pacer Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.